Cymbria Corporation
CYMBF
$52.12
-$0.77-1.46%
Weiss Ratings | CYMBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Unrated | |||
Risk Index | Unrated | |||
Risk Grade | U | |||
Reward Grade | U | |||
Rating Factors | CYMBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Unrated | |||
Growth Index | Unrated | |||
Efficiency Index | Unrated | |||
Solvency Index | Unrated | |||
Total Return Index | Unrated | |||
Volatility Index | Unrated | |||
Beta / Standard Deviation | CYMBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.10 | |||
Price History | CYMBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 0.00% | |||
60-Day Total Return | -1.46% | |||
90-Day Total Return | 1.94% | |||
Year to Date Total Return | 0.00% | |||
1-Year Total Return | 8.81% | |||
2-Year Total Return | 8.58% | |||
3-Year Total Return | 9.52% | |||
5-Year Total Return | 28.05% | |||
52-Week High % Change | -2.36% | |||
52-Week Low % Change | 1.94% | |||
Price | CYMBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $53.38 | |||
52-Week Low Price | $51.13 | |||
52-Week Low Price (Date) | Sep 11, 2024 | |||
52-Week High Price (Date) | Nov 06, 2024 | |||
Valuation | CYMBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 826.17M | |||
Enterprise Value | -- | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -- | |||
Earnings Per Share Growth | -- | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | -- | |||
Price/Book (Q) | -- | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $52.12 | |||
Enterprise Value/EBITDA (TTM) | -- | |||
Enterprise Value/EBIT | -- | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | CYMBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | -- | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | CYMBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 866-757-7207 | |||
Address | 150 Bloor Street West Toronto, ON M5S 2X9 | |||
Website | www.edgepointwealth.com/Cymbria/ | |||
Country | Canada | |||
Year Founded | 2008 | |||
Profitability | CYMBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | CYMBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | CYMBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | -- | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | -- | |||
Net Income Avl. to Common (TTM) | -- | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | -- | |||
EPS Diluted (TTM) | -- | |||
EPS Diluted Growth (Q YOY) | -- | |||
Balance Sheet | CYMBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | -- | |||
Cash Per Share (Q) | -- | |||
Total Current Assets (Q) | -- | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | -- | |||
Current Ratio (Q) | -- | |||
Book Value Per Share (Q) | -- | |||
Total Assets (Q) | -- | |||
Total Current Liabilities (Q) | -- | |||
Total Debt (Q) | -- | |||
Total Liabilities (Q) | -- | |||
Total Common Equity (Q) | -- | |||
Cash Flow | CYMBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||